Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer-Reference-Cited by-同舟云学术

Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer

Published:2016-11-19 Issue:51 Volume:7 Page:85529-85541
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chao Angel¹²,Chang Ting-Chang¹²,Lapke Nina³,Jung Shih-Ming⁴,Chi Peter⁵,Chen Chien-Hung³,Yang Lan-Yan⁶,Lin Cheng-Tao¹²,Huang Huei-Jean¹²,Chou Hung-Hsueh¹²,Liou Jui-Der¹²,Chen Shu-Jen³,Wang Tzu-Hao¹²⁷,Lai Chyong-Huey¹²

Affiliation:

1. Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan

2. Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan

3. ACTGenomics, Co. Ltd., Taiwan

4. Department of Pathology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan

5. Institute of Biochemical Sciences, College of Life Science, National Taiwan University, Taiwan

6. Clinical Trial Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan

7. School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRCA1 and BRCA2 Mutations in Carcinoma Ovary: A Prospective Cohort Study;Indian Journal of Gynecologic Oncology;2024-05-14

2. Factors predictingBRCA1/2pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis;Journal of Clinical Pathology;2023-05-23

3. Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types;Pathology - Research and Practice;2023-03

4. Epidemiology and Mortality of Ovarian Cancer in Taiwan: A Population-Based Study;Journal of Clinical Medicine;2022-09-24

5. Next-generation sequencing based detection of BRCA1 and BRCA2 large genomic rearrangements in Chinese cancer patients;Frontiers in Oncology;2022-09-06